Details
Stereochemistry | ACHIRAL |
Molecular Formula | C15H14N2O2 |
Molecular Weight | 254.2839 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
NC(=O)CC1=C(N)C(=CC=C1)C(=O)C2=CC=CC=C2
InChI
InChIKey=QEFAQIPZVLVERP-UHFFFAOYSA-N
InChI=1S/C15H14N2O2/c16-13(18)9-11-7-4-8-12(14(11)17)15(19)10-5-2-1-3-6-10/h1-8H,9,17H2,(H2,16,18)
Molecular Formula | C15H14N2O2 |
Molecular Weight | 254.2839 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Approval Year
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 15:45:15 UTC 2023
by
admin
on
Fri Dec 15 15:45:15 UTC 2023
|
Record UNII |
0J9L7J6V8C
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NDF-RT |
N0000000160
Created by
admin on Fri Dec 15 15:45:15 UTC 2023 , Edited by admin on Fri Dec 15 15:45:15 UTC 2023
|
||
|
NDF-RT |
N0000175721
Created by
admin on Fri Dec 15 15:45:15 UTC 2023 , Edited by admin on Fri Dec 15 15:45:15 UTC 2023
|
||
|
NDF-RT |
N0000175722
Created by
admin on Fri Dec 15 15:45:15 UTC 2023 , Edited by admin on Fri Dec 15 15:45:15 UTC 2023
|
||
|
NCI_THESAURUS |
C257
Created by
admin on Fri Dec 15 15:45:15 UTC 2023 , Edited by admin on Fri Dec 15 15:45:15 UTC 2023
|
||
|
WHO-VATC |
QS01BC10
Created by
admin on Fri Dec 15 15:45:15 UTC 2023 , Edited by admin on Fri Dec 15 15:45:15 UTC 2023
|
||
|
EMA ASSESSMENT REPORTS |
NEVANAC (AUTHORIZED: PAIN, POSTOPERATIVE)
Created by
admin on Fri Dec 15 15:45:15 UTC 2023 , Edited by admin on Fri Dec 15 15:45:15 UTC 2023
|
||
|
WHO-ATC |
S01BC10
Created by
admin on Fri Dec 15 15:45:15 UTC 2023 , Edited by admin on Fri Dec 15 15:45:15 UTC 2023
|
||
|
EMA ASSESSMENT REPORTS |
NEVANAC (AUTHORIZED: OPTHALMOLOGIC SURGICAL PROCEDURES)
Created by
admin on Fri Dec 15 15:45:15 UTC 2023 , Edited by admin on Fri Dec 15 15:45:15 UTC 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
C414203
Created by
admin on Fri Dec 15 15:45:15 UTC 2023 , Edited by admin on Fri Dec 15 15:45:15 UTC 2023
|
PRIMARY | |||
|
151075
Created by
admin on Fri Dec 15 15:45:15 UTC 2023 , Edited by admin on Fri Dec 15 15:45:15 UTC 2023
|
PRIMARY | |||
|
Nepafenac
Created by
admin on Fri Dec 15 15:45:15 UTC 2023 , Edited by admin on Fri Dec 15 15:45:15 UTC 2023
|
PRIMARY | |||
|
75922
Created by
admin on Fri Dec 15 15:45:15 UTC 2023 , Edited by admin on Fri Dec 15 15:45:15 UTC 2023
|
PRIMARY | |||
|
7685
Created by
admin on Fri Dec 15 15:45:15 UTC 2023 , Edited by admin on Fri Dec 15 15:45:15 UTC 2023
|
PRIMARY | |||
|
100000085451
Created by
admin on Fri Dec 15 15:45:15 UTC 2023 , Edited by admin on Fri Dec 15 15:45:15 UTC 2023
|
PRIMARY | |||
|
Nepafenac
Created by
admin on Fri Dec 15 15:45:15 UTC 2023 , Edited by admin on Fri Dec 15 15:45:15 UTC 2023
|
PRIMARY | |||
|
DB06802
Created by
admin on Fri Dec 15 15:45:15 UTC 2023 , Edited by admin on Fri Dec 15 15:45:15 UTC 2023
|
PRIMARY | |||
|
C66228
Created by
admin on Fri Dec 15 15:45:15 UTC 2023 , Edited by admin on Fri Dec 15 15:45:15 UTC 2023
|
PRIMARY | |||
|
298665
Created by
admin on Fri Dec 15 15:45:15 UTC 2023 , Edited by admin on Fri Dec 15 15:45:15 UTC 2023
|
PRIMARY | RxNorm | ||
|
DTXSID0048638
Created by
admin on Fri Dec 15 15:45:15 UTC 2023 , Edited by admin on Fri Dec 15 15:45:15 UTC 2023
|
PRIMARY | |||
|
1460317
Created by
admin on Fri Dec 15 15:45:15 UTC 2023 , Edited by admin on Fri Dec 15 15:45:15 UTC 2023
|
PRIMARY | |||
|
SUB09197MIG
Created by
admin on Fri Dec 15 15:45:15 UTC 2023 , Edited by admin on Fri Dec 15 15:45:15 UTC 2023
|
PRIMARY | |||
|
0J9L7J6V8C
Created by
admin on Fri Dec 15 15:45:15 UTC 2023 , Edited by admin on Fri Dec 15 15:45:15 UTC 2023
|
PRIMARY | |||
|
1899
Created by
admin on Fri Dec 15 15:45:15 UTC 2023 , Edited by admin on Fri Dec 15 15:45:15 UTC 2023
|
PRIMARY | |||
|
CHEMBL1021
Created by
admin on Fri Dec 15 15:45:15 UTC 2023 , Edited by admin on Fri Dec 15 15:45:15 UTC 2023
|
PRIMARY | |||
|
0J9L7J6V8C
Created by
admin on Fri Dec 15 15:45:15 UTC 2023 , Edited by admin on Fri Dec 15 15:45:15 UTC 2023
|
PRIMARY | |||
|
m7823
Created by
admin on Fri Dec 15 15:45:15 UTC 2023 , Edited by admin on Fri Dec 15 15:45:15 UTC 2023
|
PRIMARY | Merck Index | ||
|
7564
Created by
admin on Fri Dec 15 15:45:15 UTC 2023 , Edited by admin on Fri Dec 15 15:45:15 UTC 2023
|
PRIMARY | |||
|
78281-72-8
Created by
admin on Fri Dec 15 15:45:15 UTC 2023 , Edited by admin on Fri Dec 15 15:45:15 UTC 2023
|
PRIMARY | |||
|
II-86
Created by
admin on Fri Dec 15 15:45:15 UTC 2023 , Edited by admin on Fri Dec 15 15:45:15 UTC 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
METABOLITE ACTIVE -> PRODRUG |
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |
|
Name | Property Type | Amount | Referenced Substance | Defining | Parameters | References |
---|---|---|---|---|---|---|
Biological Half-life | PHARMACOKINETIC |
|
SINGLE DOSE |
|
||
Tmax | PHARMACOKINETIC |
|
SINGLE DOSE |
|
||